InsiderClue
Insiders · Profile

Scalzo Richard William

Chief Financial Officer at CRESCENT BIOPHARMA · SVP, Head of Finance & Admin. at Dyne Therapeutics. Filing since 20 Sep 2021. CIK 0001789545

CBIO CRESCENT BIOPHARMA, INC. Chief Financial Officer · 2 trades DYN Dyne Therapeutics, Inc. SVP, Head of Finance & Admin. · 32 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CBIO CRESCENT BIOPHARMA, INC.
16 Sep 2026
Chief Financial Officer
Sold on a plan
568
$10.17K
2.8%
CBIO CRESCENT BIOPHARMA, INC.
22 Jun 2026
Chief Financial Officer
Sold on a plan
1,112
$20.00K
5.2%
DYN Dyne Therapeutics, Inc.
11 Mar 2025
SVP, Head of Finance & Admin.
Sold on a plan
1,343
$15.28K
1.1%
DYN Dyne Therapeutics, Inc.
5 Mar 2025
SVP, Head of Finance & Admin.
Sold on a plan
917
$10.85K
0.7%
DYN Dyne Therapeutics, Inc.
18 Feb 2025
SVP, Head of Finance & Admin.
Sold on a plan
2,488
$34.71K
2.0%
DYN Dyne Therapeutics, Inc.
11 Dec 2024
SVP, Head of Finance & Admin.
Sold on a plan
1,455
$40.91K
1.1%
DYN Dyne Therapeutics, Inc.
18 Nov 2024
SVP, Head of Finance & Admin.
Sold on a plan
2,735
$77.13K
2.8%
DYN Dyne Therapeutics, Inc.
18 Sep 2024
SVP, Head of Finance & Admin.
Sold on a plan
1,390
$48.02K
1.4%
DYN Dyne Therapeutics, Inc.
11 Sep 2024
SVP, Head of Finance & Admin.
Sold on a plan
1,468
$46.81K
1.4%
DYN Dyne Therapeutics, Inc.
6 Sep 2024
SVP, Head of Finance & Admin.
Sold at will
126,074
$4.05M
55.4%
DYN Dyne Therapeutics, Inc.
19 Aug 2024
SVP, Head of Finance & Admin.
Sold on a plan
2,752
$124.17K
2.4%
DYN Dyne Therapeutics, Inc.
11 Jun 2024
SVP, Head of Finance & Admin.
Sold on a plan
1,331
$41.71K
1.2%
DYN Dyne Therapeutics, Inc.
10 Jun 2024
SVP, Head of Finance & Admin.
Sold on a plan
1,590
$48.07K
1.4%
DYN Dyne Therapeutics, Inc.
16 May 2024
SVP, Head of Finance & Admin.
Sold on a plan
2,588
$73.16K
2.2%
DYN Dyne Therapeutics, Inc.
11 Mar 2024
SVP, Head of Finance & Admin.
Sold on a plan
2,672
$67.54K
2.2%
DYN Dyne Therapeutics, Inc.
8 Mar 2024
SVP, Head of Finance & Admin.
Sold on a plan
86,252
$2.26M
41.4%
DYN Dyne Therapeutics, Inc.
7 Mar 2024
SVP, Head of Finance & Admin.
Sold on a plan
2,273
$58.76K
1.8%
DYN Dyne Therapeutics, Inc.
1 Mar 2024
SVP, Head of Finance & Admin.
Sold on a plan
9,311
$263.00K
7.0%
DYN Dyne Therapeutics, Inc.
29 Feb 2024
SVP, Head of Finance & Admin.
Sold on a plan
3,429
$94.30K
2.7%
DYN Dyne Therapeutics, Inc.
26 Jan 2024
SVP, Head of Finance & Admin.
Sold on a plan
13,000
$316.42K
9.5%
DYN Dyne Therapeutics, Inc.
3 Jan 2024
SVP, Head of Finance & Admin.
Sold on a plan
13,000
$244.53K
9.5%
DYN Dyne Therapeutics, Inc.
14 Dec 2023
See Remarks
Sold on a plan
2,376
$28.56K
1.9%
DYN Dyne Therapeutics, Inc.
11 Dec 2023
See Remarks
Sold at will
1,380
$14.79K
1.1%
DYN Dyne Therapeutics, Inc.
6 Dec 2023
See Remarks
Sold on a plan
1,872
$22.48K
1.4%
DYN Dyne Therapeutics, Inc.
4 Dec 2023
See Remarks
Sold on a plan
681
$8.18K
0.5%
DYN Dyne Therapeutics, Inc.
18 Sep 2023
See Remarks
Sold at will
1,290
$12.14K
3.1%
DYN Dyne Therapeutics, Inc.
12 Sep 2023
See Remarks
Sold at will
1,397
$14.54K
3.2%
DYN Dyne Therapeutics, Inc.
15 Jun 2023
See Remarks
Sold at will
10,000
$120.30K
18.7%
DYN Dyne Therapeutics, Inc.
13 Jun 2023
See Remarks
Sold at will
41,390
$532.88K
43.6%
DYN Dyne Therapeutics, Inc.
14 Mar 2023
See Remarks
Sold, plan not stated
1,311
$17.48K
2.3%
DYN Dyne Therapeutics, Inc.
12 Dec 2022
See Remarks
Sold, plan not stated
312
$3.39K
0.6%
DYN Dyne Therapeutics, Inc.
11 Mar 2022
See Remarks
Sold, plan not stated
308
$2.69K
1.1%
DYN Dyne Therapeutics, Inc.
21 Sep 2021
See Remarks
Sold, plan not stated
492
$7.93K
4.4%
DYN Dyne Therapeutics, Inc.
20 Sep 2021
See Remarks
Sold, plan not stated
367
$5.73K
3.2%
34 decisions on file.